Opticron (Sodium Cromoglicate)

Sodium Cromoglicate, the active ingredient in Opticron, is a mast cell stabilizer presented as an ophthalmic solution for ocular use. It is employed to treat allergic conjunctivitis, ocular itching and seasonal allergic eye disease in patients experiencing eye discomfort due to allergens, helping to alleviate redness, tearing and irritation.

GNH USA supplies Opticron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU regulatory standards and is distributed under strict quality controls.

Opticron acts on ocular allergic pathways to reduce inflammation and symptom severity.

- Allergic conjunctivitis: reduces ocular inflammation, redness and itching associated with allergic triggers. - Ocular itching: provides rapid relief of itchiness caused by environmental allergens. - Seasonal allergic eye disease: helps control symptoms during pollen seasons, decreasing tearing and discomfort.

Opticron may cause ocular adverse reactions, which are generally mild and transient.

Common Side Effects: - Burning sensation at the instillation site. - Stinging or mild eye irritation. - Transient blurred vision. - Mild conjunctival hyperemia. - Increased tearing. - Temporary foreign‑body sensation.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Corneal ulceration or epithelial defect. - Persistent eye pain. - Significant vision loss. - Intra‑ocular inflammation. - Severe hypersensitivity requiring immediate medical attention.

When using Opticron, consider the following precautions to ensure safe and effective therapy. - Hypersensitivity: avoid if known allergy to sodium cromoglicate or any formulation component. - Ocular infection: do not use during active eye infection without physician guidance. - Contact lens wear: remove lenses before instillation and wait before reinserting. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Monitoring: observe for worsening symptoms or unexpected irritation; seek medical advice if they persist. - Store at room temperature: keep in the original container, protect from light and moisture.

Opticron can interact with other ophthalmic agents; consider the following.

Major Interactions (Avoid): - Concurrent use with ophthalmic antihistamines containing preservatives may increase ocular irritation. - Simultaneous administration with topical non‑steroidal anti‑inflammatory eye drops may heighten risk of corneal toxicity.

Moderate Interactions (Monitor Closely): - Use with other mast cell stabilizers may amplify local side effects. - Combination with corticosteroid eye drops may require intra‑ocular pressure monitoring. - Systemic antihistamines may reduce perceived efficacy, necessitating symptom assessment.